Literature DB >> 25965736

Biogen's early Alzheimer's data raise hopes, some eyebrows.

Mark Ratner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25965736     DOI： 10.1038/nbt0515-438

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Hope for anti-amyloid antibodies surges, yet again.

Authors:  Chris Morrison
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

2.  Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.

Authors:  Dai Wang; Tim Schultz; Gerald P Novak; Susan Baker; David A Bennett; Vaibhav A Narayan
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 3.  Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications.

Authors:  Jianming Wu; Ling Li
Journal:  J Biomed Res       Date:  2016-01-02

Review 4.  Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report.

Authors:  Tetsuya Suhara; Shigeyuki Chaki; Haruhide Kimura; Makoto Furusawa; Mitsuyuki Matsumoto; Hiroo Ogura; Takaaki Negishi; Takeaki Saijo; Makoto Higuchi; Tomohiro Omura; Rira Watanabe; Sosuke Miyoshi; Noriaki Nakatani; Noboru Yamamoto; Shyh-Yuh Liou; Yuhei Takado; Jun Maeda; Yasumasa Okamoto; Yoshiaki Okubo; Makiko Yamada; Hiroshi Ito; Noah M Walton; Shigeto Yamawaki
Journal:  Int J Neuropsychopharmacol       Date:  2017-04-01       Impact factor: 5.176

5.  An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.

Authors:  Yu-Sung Cheng; Zih-Ten Chen; Tai-Yan Liao; Chen Lin; Howard C-H Shen; Ya-Han Wang; Chi-Wei Chang; Ren-Shyan Liu; Rita P-Y Chen; Pang-Hsien Tu
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.